Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
obesity
Sanofi
Novo Nordisk
AstraZeneca
Flag link:
As digital medicine explodes in the zeitgeist of healthcare, Sanofi follows peers in appointing chief digital officer
As digital medicine explodes in the zeitgeist of healthcare, Sanofi follows peers in appointing chief digital officer
Endpoints
digital pharma
digital medicine
chief technology officers
Sanofi
Flag link:
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Biopharma Dive
Regeneron
Sanofi
Amgen
Praluent
Repatha
drug pricing
PCSK9 inhibitors
Flag link:
Pharma companies clear the R&D decks in Q4
Pharma companies clear the R&D decks in Q4
Pharmaforum
R&D
GSK
Sanofi
Eli Lilly
Roche
Gilead Sciences
Flag link:
Sanofi’s latest R&D remodeling spotlights what’s hot (bispecifics) and what’s not (CTLA-4) in oncology today
Sanofi’s latest R&D remodeling spotlights what’s hot (bispecifics) and what’s not (CTLA-4) in oncology today
Endpoints
Sanofi
oncology
Flag link:
Sanofi Cuts a Whopping 38 R&D Programs to Refocus on Cancer, Immunology, and Rare Diseases
Sanofi Cuts a Whopping 38 R&D Programs to Refocus on Cancer, Immunology, and Rare Diseases
BioSpace
Sanofi
Rare Diseases
immunology
cancer
R&D
Flag link:
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Yahoo/Zacks.com
Sanofi
earnings
Flag link:
FDA approves Sanofi's Cablivi for rare clotting disease
FDA approves Sanofi's Cablivi for rare clotting disease
BioCentury
Sanofi
Cablivi
aTTP
FDA
Flag link:
CEOs of Pfizer, Merck, Sanofi to testify in Senate drug pricing hearing
CEOs of Pfizer, Merck, Sanofi to testify in Senate drug pricing hearing
Biopharma Dive
Pfizer
Sanofi
Merck
drug pricing
Senate
Flag link:
Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.
Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.
Yahoo/Bloomberg
BioNTech
IPOs
Pfizer
Sanofi
vaccines
cancer vaccines
Flag link:
Powerful Senate committee invites pharma executives to testify
Powerful Senate committee invites pharma executives to testify
Reuters
Senate
drug pricing
AbbVie
AstraZeneca
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Sanofi
Flag link:
Sanofi's isatuximab meets survival endpoint for third-line multiple myeloma
Sanofi's isatuximab meets survival endpoint for third-line multiple myeloma
BioCentury
Sanofi
FDA
EMA
isatuximab
relapsed or refractory multiple myeloma
Multiple Myeloma
Flag link:
Sanofi Raises Public Health Questions on Use of Nonsense Suffixes With New Vaccines
Sanofi Raises Public Health Questions on Use of Nonsense Suffixes With New Vaccines
RAPS.org
Sanofi
vaccines
drug names
suffixes
Flag link:
On heels of drug pricing hearings, Democratic lawmakers kick off insulin probe
On heels of drug pricing hearings, Democratic lawmakers kick off insulin probe
Fierce Pharma
Sanofi
Novo Nordisk
diabetes
insulin
drug pricing
Flag link:
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin
Flag link:
Sanofi expands multitargeting toolbox with Biomunex deal
Sanofi expands multitargeting toolbox with Biomunex deal
BioCentury
Sanofi
Biomunex Pharmaceuticals
drug development
Flag link:
Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma
BioSpace
JPMHC 2019
M&A
Eli Lilly
Loxo Oncology
SAGE Therapeutics
Sanofi
Regeneron
Bristol-Myers Squibb
Celgene
Novartis
Gilead Sciences
Flag link:
JPM: Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons
JPM: Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons
Fierce Pharma
Sanofi
Dengvaxia
vaccines
dengue
JPMHC 2019
Flag link:
Sanofi pays Regeneron $462M to exit immuno-oncology R&D pact
Sanofi pays Regeneron $462M to exit immuno-oncology R&D pact
Fierce Biotech
Sanofi
Regeneron
immuno-oncology
Flag link:
After Pfizer, Sanofi becomes partner of German biotech BioNTech
After Pfizer, Sanofi becomes partner of German biotech BioNTech
GoinPharma
Sanofi
Pfizer
BioNTech
solid tumors
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »